Takeda's Alogliptin Among MHLW Approval Recommendations; Pfizer, Alexion Also Gain

Japan's First Committee on New Drugs at the Ministry of Health, Labor and Welfare recommended for approval three Takeda drugs: alogliptin and pioglitazone/metformin combination - both for type 2 diabetes - and combination drug candesartan/amlodipine for hypertension